We are live on ! Find out more
BNGOW

Bionano Genomics, Inc. Warrant

Delisted

BNGOW was delisted on the 17th of August, 2023.

5 hedge funds and large institutions have $56K invested in Bionano Genomics, Inc. Warrant in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding

Funds holding: 35 (+2)

47% less capital invested

Capital invested by funds: $105K → $56K (-$49K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

BNGOW Hedge Fund Activity: Q4 2019 in Review

5 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics, Inc. Warrant (BNGOW) for Q4 2019, worth a combined $56K — down 47% from $105K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new BNGOW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $14.9K. The largest seller was Monashee Investment Management, cutting an estimated $15.7K.

  • 5 institutional investors held Bionano Genomics, Inc. Warrant (BNGOW) as of Q4 2019, up from 3 in Q3 2019.
  • Funds reported $56K of Bionano Genomics, Inc. Warrant stock for Q4 2019, down 47% quarter-over-quarter.
  • 2 funds opened new Bionano Genomics, Inc. Warrant positions in Q4 2019 and 0 closed out, a net change of +2 holders.
  • The largest Bionano Genomics, Inc. Warrant buyer in Q4 2019 was Susquehanna International Group, an estimated $14.9K added.
  • The largest Bionano Genomics, Inc. Warrant seller in Q4 2019 was Monashee Investment Management, an estimated $15.7K sold.

Based on aggregated 13F filings for Q4 2019.